ReviewCancers2026

The Immunologic Paradox of BTK Inhibitors in Chronic Lymphocytic Leukemia: Selectivity, Hypogammaglobulinemia, and Infection Risk.

Mihaela Andreescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.